PHARMATECA » Search Articles by Keyword

Found: 133 articles

Article	Edition
I.B. Zhurtova, A.M. Gubachikova, L.S. Aramisova, H.A. Abdul Moati, L.A. Anaeva Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection	№12 / 2023
M.B. Antsiferov, O.M. Koteshkova, D.M. Antsiferova, N.A. Demidov Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution	№12 / 2023
E.V. Biryukova Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin	№12 / 2023
G.A. Ignatenko, A.E. Bagriy, A.V. Prikolota, O.A. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation	№12 / 2023
Kh.S. Astamirova, A.I. Gatina, Ya.S. Gorbunova, N.A. Demidov, T.S. Ivanenko, M.I. Kolesnikova, O.A. Lapteva, I.V. Morozova, V.A. Parshina, O.Yu. Presnyakova, E.Yu. Smirnova, N.P. Smirnova, M.A. Startseva, Z.A. Khamrazhanov, N.I. Kholmskaya How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary	№12 / 2023
N.A. Demidov Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus	№12 / 2023
V.I. Petrov, O.V. Shatalova, M.S. Klykova, N.P. Stetsky The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus	№12 / 2023
S.V. Podachina, E.V. Biryukova, I.V. Solovievа Combination therapy for type 2 diabetes maintains its position. Clinical case	№3 / 2023
E.Yu. Smirnova Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series	№3 / 2023
E.V. Biryukova, M.V. Shinkin, I.A. Morozovа Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination	№3 / 2023
M.B. Antsiferov, O.M. Koteshkova, O.V. Dukhareva, N.A. Demidov, M.S. Novikova Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus	№11-12 / 2022
N.A. Petunina, N.S. Martirosyan, F.V. Valeeva Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review	№11-12 / 2022